Muscarinic antagonists are anxiogenic in rats tested in the black-white box

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 1, 1996, Pages 57-63

  Smythe, James W ^a   Murphy, Deborah ^a   Bhatnagar, Seema ^b   Timothy, Carryl ^a   Costall, Brenda ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acetylcholine; anxiety; arousal; black white box; central; hypothalamic pituitary adrenal axis; peripheral; scopolamine; stress; theta

Indexed keywords

ANXIOGENIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE; SCOPOLAMINE METHYL BROMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; APPARATUS; AROUSAL; BEHAVIOR; CHOLINERGIC SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEAR; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THETA RHYTHM;

EID: 0029931780     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02130-2     Document Type: Conference Paper

References (37)

1. Azmitia, E. C.; McNaughton, N.; Tsaltas, L.; Fillenz, M.; Gray, J. A. Interactions between hippocampal serotonin and the pituitary-adrenal axis in the septal driving of hippocampal theta-rhythm. Neuroendocrinology 39:471-475; 1984.
2. 3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 338:762-763; 1989.
3. 3 receptor antagonist, on cognition in rodents and primates. Pharmacol. Biochem. Behav. 35:955-962; 1990.
4. Bennett, M. C.; Diamond, D. M.; Fleshner, M.; Rose, G. M. Serum corticosterone levels predicts the magnitude of hippocampal primed burst potentiation and depression in urethane-anesthetizedrats. Psychobiology 19:301-307; 1991.
5. Bhatnagar, S.; Smythe, J. W.; Meaney, M. J. Hippocampal cholinergic blockade elevates stress-induced corticosterone (CORT) secretion. Soc. Neurosci. Abstr. 20:935; 1994.
6. Bierer, L. M.; Haroutunian, V.; Gabriel, S.; Knott, P. J.; Carlin, L. S.; Purohit, D. P.; Perl, D. P.; Schmeidler, J.; Kanof, P.; Davis, K. L. Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits. J. Neurochem. 64:749-760; 1995.
7. Bland, B. H. The physiology and pharmacology of hippocampal formation theta rhythms. Prog. Neurobiol. 26:1-54; 1986.
8. Bland, B. H.; Colom, L. V. Extrinsic and intrinsic properties underlying oscillations and synchrony in limbic cortex. Prog. Neurobiol. 41:157-208; 1993.
9. Bray, J. H.; Maxwell, S. E. Analyzing and interpreting significant MANOVAs. J. Educat. Res. 52:340-367; 1982.
10. Carey, G. J.; Costall, B.; Domeney, A. M.; Gerrard, P. A.; Jones, D. N. C.; Naylor, R. J.; Tyers, M. B. Ondasetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset. Pharmacol. Biochem. Behav. 42:75-83; 1992.
11. Carey, G. J.; Costall, B.; Domeney, A. M.; Jones, D. N. C.; Naylor, R. J. Behavioural effects of anxiogenic agents in the common marmoset. Pharmacol. Biochem. Behav. 42:143-153; 1992.
12. Cheng, C. H. K.; Costall, B.; Ge, J.; Naylor, R. J. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely moving rats. Br. J. Pharmacol. 110:1079-1084; 1993.
13. 3 receptor antagonist, RS-42358-197, in animal models of anxiety. Eur. J. Pharmacol. 234: 91-99; 1993.
14. Costall, B.; Jones, B. J.; Kelly, M. E.; Naylor, R. J.; Tomkins, D. M. Exploration of mice in a black and white test box: Validation as a model of anxiety. Pharmacol. Biochem. Behav. 32:777-785; 1989.
15. Delacour, J. A central activation role for the hippocampus: A viewpoint. Neurosci. Res. Commun. 16:1-10; 1995.
16. Diamond, D. M.; Bennett, M. C.; Fleshner, M.; Rose, G. M. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus 2:421-430; 1992.
17. Dunnet, S. B.; Everitt, B. J.; Robbins, T. W. The basal forebrain cortical cholinergic system: Interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14:494-501; 1991.
18. Feldman, S.; Weidenfeld, J. Neural mechanisms involved in the corticosteroid feedback effects on the hypothalomo-pituitary-adrenocortical axis. Prog. Neurobiol. 45:129-141; 1995.
19. Fibiger, H. C. Cholinergic mechanisms in learning, memory, and dementia: A review of recent evidence. Trends Neurosci. 14:220-223; 1991.
20. Hatzinger, M.; Z'Brun, A.; Hemmeter, U.; Seifritz, E.; Baumann, F.; Holsboer-Trachsler, E.; Heuser, I. J. Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease. Neurobiol. Aging 16:205-209; 1995.
21. Hess, C.; Blozovski, D. Hippocampal muscarinic cholinergic mediation of spontaneous alternation and fear in the developing rat. Behav. Brain Res. 24:203-214; 1987.
22. Janowsky, D. S.; Risch, S. C. Role of acetylcholine mechanisms in the affective disorders. In: Meltzer, H. Y., ed. Psychopharmacology: The third generation of progress. New York: Raven Press; 1987:527-533.
23. Karczmar, A. G. Cholinergic substrates of cognition and organism-environment interaction. Prog. Neuropsychopharmacol. Biol. Psychiatry 19:187-211; 1995.
24. Lawson, V. H.; Bland, B. H. The role of the septohippocampal pathway in the regulation of hippocampal field activity and behavior: Analysis by the intraseptal microinfusion of carbachol, atropine, and procaine. Exp. Neurol. 120:132-144; 1993.
25. Matsuoka, N.; Maeda, N.; Ohkubo, Y.; Yamaguchi, I. Differential effects of physostigmine and pilocarpine on the spatial memory deficits produced by two septo-hippocampal deafferentations in rats. Brain Res. 559:233-240; 1991.
26. Meaney, M. J.; O'Donnell, D.; Viau, V.; Bhatnagar, S.; Sarrieau, A.; Smythe, J. W.; Shanks, N.; Walker, C. D. Corticosteroid receptors in the rat brain and pituitary during development and hypothalamic-pituitary-adrenal (HPA) function. In: McLaughlin, P.; Zagon, I., eds. Receptors and the developing nervous system. London: Chapman and Hill; 1993:163-201.
27. M'Harzi, M.; Palou, A.-M.; Oberlander, C.; Barzaghi, F. Antagonism of scopolamine-induced memory impairments in rats by the muscarinic agonist RU 35926 (CI-979). Pharmacol. Biochem. Behav.51:119-124; 1995.
28. Mizuno, T.; Endo, Y.; Arita, T.; Kimura, F. Acetylcholine release in the rat hippocampus as measured by the microdialysis method correlates with motor activity and exhibits a diurnal variation. Neuroscience 44:607-612; 1991.
29. Nilsson, O. G.; Kalen, P.; Rosengren, E.; Bjorklund, A. Acetylcholine release in the rat hippocampus as studied by microdialysis is dependent on axonal impulse flow and increases during behavioural activation. Neuroscience 36:325-338; 1990.
30. Purves, D.; Bonardi, C.; Hall, G. Enhancement of latent inhibition in rats with electrolytic lesions of the hippocampus. Behav. Neurosci. 109:366-370; 1995.
31. Reilly, S.; Harley, C.; Revusky, S. Ibotenate lesions of the hippocampus enhance latent inhibition in conditioned taste aversion and increase resistance to extinction in conditioned taste preference. Behav. Neurosci. 107:996-1004; 1993.
32. Rodgers, R. J.; Cole, J. C. Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety. Behav. Pharmacol. 6:283-289; 1995.
33. Smythe, J. W.; Murphy, D.; Bhatnagar, S.; Dallman, M.; Costall, B. Cholinergic blockade produces increased endocrine and behavioral measures of fear in rats. Soc. Neurosci. Abstr. 21:463; 1995.
34. Sutherland, R. J.; Wishaw, I. Q.; Regehr, J. Cholinergic receptor blockade impairs spatial localization by use of distal cues in the rat. J. Comp. Physiol. Psychol. 96:563-573; 1982.
35. Vanderwolf, C. H. Hippocampal electrical activity and voluntary movement in the rat. Electroencephalogr. Clin. Neurophysiol. 26: 407-418; 1969.
36. Young, S. L.; Bohenek, D. L.; Fanselow, M. S. Scopolamine impairs acquisition and faciltates consolidation of fear conditioning: Differential effects for tone vs. context conditioning. Neurobiol. Learn. Memory 63:174-180; 1995.
37. Zhu, X.-O.; McNaughton, N. The interaction of serotonin depletion with anxiolytics and antidepressants on reticular-licited hippocampal RSA. Neuropsychopharmacology 33:1597-1605; 1994.